Searched for
HOSPIRA HEALTHCARE INDIA
Pfizer Inc recalls 1.8 million vials of antibiotics"Piperacillin and tazobactam have been found to contain elevated levels of impurities that may result in decreased potency," a notification...- Lapses push Pfizer to shut Chennai unit temporarilyThe site is grappling with adverse reviews for a few years. It was served a warning letter by the US Food and Drug Administration (FDA) in ...
- Pfizer adds to list of drugmakers under lens for deviating from good manufacturing practicesThe USFDA and MHRA submitted their inspection observation reports, which Pfizer said it has reviewed in depth.
- Baxter emerges as frontrunner to buy KKR-backed Gland Pharma for $1.1-1.2 billionHyderabad-headquartered Gland is a leading contract manufacturers of injectables, supplying to pharma majors in India and US like Dr Reddy’...
- Government to commission study on impact of FDI in pharmaceutical companiesThe government is likely to commission a study soon to assess the impact of foreign direct investment in existing pharmaceutical companies
- India Inc's August foreign borrowing up 48% at $751 millionHowever, the amount borrowed by Indian firms from overseas markets in August this year was much lower than over USD 2.14 billion, raised in...
- Overseas borrowing by Indian firms drops 42% in JulyIndia Inc's external commercial borrowing fell by 42.5 per cent to $ 2.14 billion during July 2015 compared to the same period last year.
- Cadila Healthcare to acquire Claris Lifesciences for Rs 3,400 croreBoth sides are currently engaged in last-minute due diligence negotiations involving tax and other financial matters, said at least five so...
- Mylan to invest $5 billion in Andhra Pradesh to expand presenceDuring the meeting Naidu said that he wants to see Andhra Pradesh as a healthcare hub with health and education being government's prioriti...
- India Inc's Septemebr foreign borrowing down 5.3% on yr at $3.17 bnIndia Inc raised $ 3.17 billion from overseas markets in September 2014, down 5.3 per cent from a year ago, RBI data showed.
- India Inc's foreign borrowings fall to $ 1.46 billion in MayGeneral Motors India raised $ 244.50 million for general corporate purpose (11.8 years) and Mylan Laboratories borrowed $ 200 million.
- Nine foreign investment proposals worth Rs 798.73 crore approvedThe Ministry said it approved the nine proposals following recommendations of the Foreign Investment Promotion Board (FIPB).
- Indian drug manufacturing sites face USFDA's warning delugeThe US drug regulator has issued warning letters to Indian drugmakers Promed Exports and Posh Chemicals for violation of good manufacturing...
- Orchid Chemicals gets CCI nod for Hospira dealCompetition Commission of India today said it has approved a proposed sale by Orchid Chemicals and Pharmaceuticals Ltd (OCPL) of its certai...
- US based Hospira to buy Orchid's API manufacturing, R&D units in $200 million dealOrchid Chemicals today said it will sell various assets including active pharmaceutical ingredients (API) business and a R&D facility to Ho...
- Cadila Healthcare targets revenues of $ 3 billion by 2015After a subdued performance in the first nine months of FY12, Cadila Healthcare logged an improved show for the quarter ended March 2012.
- Review on FDI in Indian pharma sector soon, says Pranab MukherjeeAmidst a debate whether FDI in pharma sector should be regulated ,Pranab Mukherjee said a decision on the issue would be taken.
- Stocks to watch: Hero Honda, ITC, Tata Motors, Orchid Chemicals, Cholamandalam DBS FinanceHero Honda declared its highest dividend yet on Tuesday, and held out the possibility of another payout next month, part of the company’s p...
- Orchid Chemicals to retire $260 mn in short-term debtsOrchid Chemicals and Pharmaceuticals, which sold off its pharma business to Hospira for a consideration of $400 mn, plans to use the funds ...
- Sanofi to eclipse Sun’s Eloxatin planFrance’s largest pharma company, Sanofi-Aventis, is suing India’s Sun Pharmaceuticals and Hospira’s Mayne Pharma to prevent the latter from...
Load More
